Breaking News Instant updates and real-time market news.

INTC

Intel

$39.34

-0.04 (-0.10%)

, CNP

CenterPoint Energy

$28.99

0.21 (0.73%)

04:55
10/05/17
10/05
04:55
10/05/17
04:55

Oracle to hold a user conference

Oracle OpenWorld is being held in San Francisco on October 1-5.

INTC

Intel

$39.34

-0.04 (-0.10%)

CNP

CenterPoint Energy

$28.99

0.21 (0.73%)

ACN

Accenture

$135.16

0.91 (0.68%)

NVDA

Nvidia

$180.87

1.5 (0.84%)

EXC

Exelon

$38.19

0.35 (0.92%)

VRTS

Virtus Investment

$119.85

2.9 (2.48%)

EQIX

Equinix

$442.97

0.61 (0.14%)

DELL

Taken Private

$13.86

(0.00%)

DGX

Quest Diagnostics

$92.96

0.07 (0.08%)

PRFT

Perficient

$19.88

0.11 (0.56%)

N

NetSuite

$0.00

(0.00%)

MSTR

MicroStrategy

$130.99

1.72 (1.33%)

IBM

IBM

$146.48

-0.3 (-0.20%)

INFY

Infosys

$14.51

-0.04 (-0.27%)

ADP

ADP

$111.40

0.69 (0.62%)

ORCL

Oracle

$48.90

0.21 (0.43%)

  • 05

    Oct

  • 05

    Oct

  • 05

    Oct

  • 08

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 03

    Nov

  • 05

    Nov

  • 15

    Nov

  • 30

    Nov

  • 07

    Dec

  • 11

    Dec

INTC Intel
$39.34

-0.04 (-0.10%)

09/27/17
SBSH
09/27/17
NO CHANGE
Target $185
SBSH
Buy
Citi sees no major impact for Nvidia from Tesla's move to Intel
Bloomberg's report that Tesla (TSLA) is working with Intel (INTC) to replace Nvidia (NVDA) on infotainment is a negative headline but will have no major impact, Citi analyst Atif Malik tells investors in a research note. While infotainment today makes up the bulk of Nvidia's automotive sales and represents a $2B serviceable addressable market, autonomous vehicles represents the growth opportunity with an $8B addressable market by 2025, the analyst contends. He estimates that average selling prices on infotainment systems are $100 versus $1000-plus for autonomous vehicle systems. Nvidia is now more focused on the higher margin autonomous driving market and next generation cockpit opportunities, Malik tells investors. Further, he estimates Tesla is less than 1% of Nvidia's overall sales currently, which includes both infotainment and autonomous systems. He points out that his discussion at Citi's recent technology conference with Tesla indicates the carmaker "feels great" about its relationship with Nvidia on self-driving cars, or "significantly better" versus Intel's Mobileye in the past. Malik has a Buy rating on Nvidia with a $185 price target.
10/04/17
JEFF
10/04/17
NO CHANGE
Target $5
JEFF
Buy
Jefferies says Intelsat C-band proposal a 'welcome, but speculative' development
After news that Intelsat (I) and Intel (INTC) have submitted a proposal to share a portion of the C-band with mobile operators, Jefferies analyst Giles Thorne said that while it was not made explicit he would assume that Intelsat wants to lease access to its spectrum. The analyst, who called this news "a welcome, but speculative, development," said it is challenging to estimate the size of a potential revenue stream, adding that if the FCC were to approve the plan "there won't be a 'quid' without a 'quo'." Thorne keeps a Buy rating and $5 price target on Intelsat shares, which gained about 11% yesterday to close at $5.37.
10/02/17
BWSF
10/02/17
NO CHANGE
BWSF
Sell
BWS Financial sees Applied Optoelectronics sales to Amazon softening further
BWS Financial analyst Hamed Khorsand said he believes Applied Optoelectronics (AAOI) sales to Amazon (AMZN) have softened even more as the company moves away from 40G. He also thinks Intel's (INTC) start of shipments of a competing CWDM4 transceivers poses a threat to 100G revenue Applied has been generating from Facebook (FB). Khorsand keeps his Sell rating on Applied Optoelectronics shares.
10/03/17
CHLM
10/03/17
NO CHANGE
Target $80
CHLM
Buy
Applied Optoelectronics price target lowered to $80 from $95 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Applied Optoelectronics (AAOI) to $80 from $95 on 40G transition acceleration and Intel (INTC) competitive threat. Nonetheless, the analyst says 100G+ remains robust, and Applied Optoelectronics' cost structure enables it to compete effectively. He reiterates a Buy rating on Applied Optoelectronics' shares.
CNP CenterPoint Energy
$28.99

0.21 (0.73%)

08/14/17
FBCO
08/14/17
UPGRADE
Target $29
FBCO
Neutral
CenterPoint Energy upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Michael Weinstein upgraded CenterPoint Energy to Neutral with a $29 price target citing solid utility fundamentals with a 4% total return potential over the next 12 months.
03/16/17
RBCM
03/16/17
DOWNGRADE
RBCM
Sector Perform
CenterPoint Energy downgraded based on valuation at RBC Capital
As noted earlier, RBC Capital downgraded CenterPoint Energy to Sector Perform from Outperform. Analyst Insoo Kim downgraded the stock based on valuation. Target to $28 from $27.
06/29/17
JPMS
06/29/17
DOWNGRADE
Target $29
JPMS
Neutral
CenterPoint Energy assumed with a Neutral from Overweight at JPMorgan
JPMorgan analyst Christopher Turnure downgraded CenterPoint Energy to Neutral after assuming coverage of the name. The analyst says the outcome of the company's Enable stake sale is still not clear. He raised his price target for the shares to $29 from $25.
08/14/17
FBCO
08/14/17
UPGRADE
FBCO
Neutral
CenterPoint Energy upgraded to Neutral from Underperform at Credit Suisse
ACN Accenture
$135.16

0.91 (0.68%)

09/29/17
CANT
09/29/17
NO CHANGE
Target $151
CANT
Overweight
Accenture price target raised to $151 from $135 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for Accenture to $151 saying the company reported a "strong" Q4. The analyst views the company's acquisition activity as a positive and believes it remains well positioned to take market share in the outsourcing industry. He keeps an Overweight rating on Accenture.
10/03/17
SUSQ
10/03/17
DOWNGRADE
SUSQ
Neutral
Accenture downgraded to Neutral from Positive at Susquehanna
09/26/17
KEYB
09/26/17
NO CHANGE
KEYB
Accenture, IBM to benefit from shift to AI, says KeyBanc
KeyBanc analyst Arvind Ramnani says that while the promise of Artificial Intelligence is exciting, the path is complex, which he believes provides a "unique opportunity" for IT Services firms that can accelerate its adoption. The analyst thinks Accenture (ACN), IBM (IBM), DXC Technology (DXC), and EPAM Systems (EPAM), among others, could benefit from the shift to AI.
09/28/17
SOCG
09/28/17
DOWNGRADE
Target $144
SOCG
Hold
Accenture downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Richard Nguyen downgraded Accenture to Hold but raise his price target for the shares to $144 from $142 following the company's Q4 results.
NVDA Nvidia
$180.87

1.5 (0.84%)

10/02/17
RHCO
10/02/17
NO CHANGE
RHCO
Nvidia price target raised to $200 from $181 at SunTrust
SunTrust analyst William Stein increased his price target on Nvidia as he says new products and customer contracts announced by the company involving the use of AI in datacenters make his bullish scenario for Nvidia more likely. He keeps a Buy rating on the shares.
10/04/17
LEHM
10/04/17
NO CHANGE
Target $200
LEHM
Equal Weight
Nvidia price target raised to $200 from $140 at Barclays
Barclays analyst Blayne Curtis raised his price target for Nvidia shares to $200 while keeping an Equal Weight rating on the name. The launch of Volta based client graphic processing units in early 2018 should widen the company's lead, Curtis tells investors in a research note on the U.S. Semiconductors space titled "Crypto Tailwind Likely Extends into Next Year." The GPU market is still in shortage but should start to recover into the end of the year, the analyst writes. He sees this as positive for both Nvidia and AMD (AMD). The analyst raised his price target for AMD shares to $10 from $9 but keeps an Underweight rating on the name. Curtis remains cautious saying AMD's share gains are not materializing to justify the current stock price.
09/28/17
NEED
09/28/17
NO CHANGE
NEED
Nvidia weakness overdone, says Needham
Needham analyst Rajvindra S. Gil says that Nvidia (NVDA) has fallen about 6% in the last week, partly due to concerns over the reported loss of its infotainment business with Tesla (TSLA). The analyst believes that the decline is overdone, as he says that Tesla's contribution to Nvidia's financial results will be minimal in any conceivable scenario, while ADAS, not infotainment, will generate significant revenue for Nvidia. The analyst keeps a $200 price target and a Buy rating on Nvidia.
09/29/17
SBSH
09/29/17
NO CHANGE
Target $210
SBSH
Buy
Citi boosts Nvidia target to $210 on artificial intelligence opportunity
Citi analyst Atif Malik raised his price target for Nvidia (NVDA) shares to $210 to reflect higher data center inference sales supported by recent announcements with China's Alibaba Cloud (BABA), Baidu (BIDU), and Tencent (TCEHY). Nvidia closed yesterday down 5c to $175.68. The Street views the company as dominant in training but an underdog in inferencing, Malik tells investors in a research note titled "The State of AI Today; Raising TP on AI Inference Opportunity." He points out that Nvidia's new TensorRT software platform and Tesla (TSLA) GPU accelerators are 40 times faster than CPUs at one-tenth the cost of CPU-based solutions. Nvidia targets to participate in high level edge inferencing for smart cities, manufacturing, and robotics end markets, Malik writes. He adds that his firm's updated proprietary gaming survey indicates AMD's (AMD) new Vega graphics cards represent a "limited threat." The analyst believes Nvidia's risk/reward remains skewed to the upside and he keeps a Buy rating on the shares.
EXC Exelon
$38.19

0.35 (0.92%)

07/17/17
WOLF
07/17/17
UPGRADE
WOLF
Outperform
Exelon upgraded to Outperform from Peer Perform at Wolfe Research
07/17/17
DBAB
07/17/17
NO CHANGE
Target $41
DBAB
Buy
Exelon scored big legal win on Friday, says Deutsche Bank
Deutsche Bank analyst Jonathan Arnold says he learned Friday that the judge in the challenge brought against the Illinois Zero Emission Credit program had ruled categorically in favor of Exelon's motion to dismiss the case. The decision, while unlikely to be the final word, looks like an "important and comprehensive first win" for Exelon in a case with direct implications for $235M of annual revenues, Arnold tells investors in a research note. He has a Buy rating on the shares with a $41 price target.
07/27/17
SBSH
07/27/17
UPGRADE
SBSH
Buy
Exelon upgraded to Buy from Neutral at Citi
06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Exelon merchant assets 'significantly undervalued,' says SunTrust
After meeting with Exelon's CFO, SunTrust analyst Ali Agha says that the company's merchant assets are significantly undervalued. He expects the company, within 18 months, to either use a portion of the unit's free cash flow to buy back shares or sell a stake in the business. The analyst raised his price target on the stock to $40 from $39 and keeps a Buy rating on the shares.
VRTS Virtus Investment
$119.85

2.9 (2.48%)

09/08/17
LEHM
09/08/17
INITIATION
Target $113
LEHM
Equal Weight
Virtus Investment initiated with an Equal Weight at Barclays
Barclays analyst Jeremy Campbell started Virtus Investment with an Equal Weight rating and $113 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
06/01/17
MSCO
06/01/17
INITIATION
MSCO
Equal Weight
Virtus Investment initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Michael Cyprys initiated Virtus Investment Partners with an Equal Weight and a $105 price target.
07/31/17
FBCO
07/31/17
UPGRADE
FBCO
Outperform
Virtus Investment upgraded to Outperform from Neutral at Credit Suisse
07/31/17
07/31/17
UPGRADE
Target $147

Outperform
Virtus Investment upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Ari Ghosh upgraded to Outperform from Neutral following Q2 results. Over the last seven months, the company fundamentals and macro factors have improved, resulting in his 2018 outlook for positive net flows, large cash generation and solid margin and EPS growth, the analyst adds. Additionally, He believes the company's relative valuation is "very attractive." Ghosh also raised his price target on the shares to $147 from $141.
EQIX Equinix
$442.97

0.61 (0.14%)

06/30/17
FBCO
06/30/17
INITIATION
Target $510
FBCO
Outperform
Equinix initiated with an Outperform at Credit Suisse
Credit Suisse analyst Sami Badri started coverage of the Data Center REITS, initiating Equinix with an Outperform rating and $510 price target, contending that the company has a "wide lead" on interconnection peering points and customer interconnection services and that it is leading the "colocation boom."
05/11/17
ADAM
05/11/17
NO CHANGE
Target $525
ADAM
Buy
Equinix price target raised to $525 from $465 at Canaccord
Canaccord analyst Paul Morgan raised his price target on Equinix to $525 from $465 following meetings with management. The analyst said he sees near-term upside from the portfolio's top asset, selling into 600 new customer logos, and absorbing capacity from other locations. Morgan sees Equinix as well positioned to deliver double digit secular growth and he reiterated his Buy rating on the shares.
05/25/17
NOMU
05/25/17
INITIATION
Target $490
NOMU
Buy
Equinix initiated with a Buy at Nomura Instinet
Nomura initiated Jeffrey Kvaal initiated Equinix with a Buy and a $490 price target saying its scale positioned it well for the cloud migration, which the firm's networking coverage suggests is accelerating. The analyst's estimates are above consensus as each new connection raises the value of Equinix's connectivity.
09/11/17
MUFG
09/11/17
NO CHANGE
Target $504
MUFG
Equinix price target raised to $504 after European acquisitions at MUFG
After Equinix (EQIX) announced an agreement to purchase Itconic and Cloudmas from the Carlyle Group (CG), MUFG analyst Stephen Bersey said he thinks Itconic's data centers may have room to be developed and that Equinix can generate added upside from existing space by increasing utilization rates. The analyst, who called the European acquisitions "a solid strategic addition," raised his price target on Equinix to $504 from $471 and keeps an Overweight rating on the stock.
DELL Taken Private
$13.86

(0.00%)

DGX Quest Diagnostics
$92.96

0.07 (0.08%)

09/28/17
FBCO
09/28/17
NO CHANGE
Target $99
FBCO
Neutral
Quest Diagnostics price target lowered to $99 from $110 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright lowered her price target for Quest Diagnostics to $99 from $110, citing hurricanes headwinds and a harsher pricing environment, in light of recent PAMA news. The analyst reiterates a Neutral rating on the shares.
09/25/17
09/25/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UAA) downgraded to Neutral from Buy at Guggenheim. 2. VF Corp. (VFC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Edward Yruma saying the company's "consistent" results are adequately reflected in the current valuation. 3. Quest Diagnostics (DGX) downgraded to Market Perform from Outperform at Raymond James with analyst Nicholas Jansen citing the preliminary 2018 Clinical Laboratory Fee Schedule, or CLFS, rates released Friday evening, which creates an overhang. 4. AbbVie (ABBV) downgraded to Neutral from Buy at UBS with analyst Marc Goodman saying that shares are up 40% year-to-date. 5. Albemarle (ALB) downgraded to Neutral from Outperform at Baird with analyst Ben Kallo saying he thinks near-term execution is largely priced into the stock and he believes the shares are fully valued at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/25/17
ADAM
09/25/17
NO CHANGE
ADAM
Genomic Health, Vermillion among 'few winners' after PAMA news, says Canaccord
After the CMS released the proposed 2018 draft Medicare reimbursement rates for clinical lab tests under the Protecting Access to Medicare Act, or PAMA, which marks a major overhaul of Medicare reimbursement for tests, Canaccord analyst Mark Massaro said the cuts were greater than he expected. He identifies the "losers" after the news as LabCorp (LH), Quest Diagnostics (DGX) and GenMark (GNMK) while he sees Genomic Health (GHDX), VeraCyte (VCYT) and Vermillion (VRML) as among the "few winners."
09/25/17
RHCO
09/25/17
NO CHANGE
RHCO
LabCorp, Quest should be bought on 'meaningful weakness,' says SunTrust
SunTrust analyst David MacDonald says that new metrics released by CMS are expected to decrease Medicare payments for lab tests by 21.9%, but he says that reductions for most tests "are capped at 10% from C18-C20 and capped at 15% from CY21-CY23." The analyst says that the exposure of .LabCorp (LH) and, Quest (DGX) is "manageable," and he recommends buying the shares on any "meaningful" weakness.
PRFT Perficient
$19.88

0.11 (0.56%)

11/04/16
11/04/16
DOWNGRADE
Target $17

Market Perform
Perficient downgraded to Market Perform on Q3, guidance miss at Avondale
As previously reported, Avondale downgraded Perficient to Market Perform from Outperform and lowered its price target to $17 from $22. Analyst Peter Heckmann said Perficient reported disappointing Q3 results and guidance due to delays in project starts and bookings pressure and recommends staying on the sidelines until the outlook becomes more clear.
11/04/16
AVON
11/04/16
DOWNGRADE
AVON
Market Perform
Perficient downgraded to Market Perform from Outperform at Avondale
N NetSuite
$0.00

(0.00%)

10/26/16
BOFA
10/26/16
INITIATION
Target $68
BOFA
Underperform
NetSuite reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Kash Rangan reinstated NetSuite (N) with an Underperform with a $68 price target from No Rating.
10/28/16
DADA
10/28/16
DOWNGRADE
DADA
Underperform
NetSuite downgraded to Underperform from Neutral at DA Davidson
10/26/16
10/26/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL) initiated with a Buy at Mizuho. 2. Five Below (FIVE) initiated with a Buy at Longbow. 3. NetSuite (N) reinstated with an Underperform at BofA/Merrill. 4. Adient (ADNT) initiated with a Buy at Northcoast. 5. Party City (PRTY) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
MSTR MicroStrategy
$130.99

1.72 (1.33%)

07/28/17
DBAB
07/28/17
DOWNGRADE
Target $180
DBAB
Hold
MicroStrategy downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Karl Keirstead downgraded MicroStrategy (MSTR) to Hold and cut his price target for the shares to $180 from $220 citing the "disappointing" Q2 results as well as the company's strategy shift. Last night's results marked the third consecutive quarter of license revenue declines, Keirstead tells investors in post-earnings research note. MicroStrategy is now pivoting to a "much more aggressive" spending strategy in response to competition from Tableau (DATA) and Microsoft (MSFT), the analyst adds. He believes the stock has more downside risk.
07/31/17
FANA
07/31/17
DOWNGRADE
Target $140
FANA
Equal-Weight
MicroStrategy downgraded to Equal-Weight from Overweight at First Analysis
First Analysis analyst Frank Sparacino downgraded MicroStrategy to Equal-Weight and cut his price target for the shares to $140 from $225. Following a "disappointing" Q2 and first half of 2017, the company's investment's "will take time to bear fruit," the analyst writes to investors.
09/15/17
DBAB
09/15/17
NO CHANGE
Target $150
DBAB
Buy
MicroStrategy price target lowered to $150 from $180 at Deutsche Bank
Deutsche Bank analyst Karl Keirstead cut his price target for MicroStrategy shares to $150 on reduced margin assumptions following the company's presentation at his firm's conference. MicroStrategy provided details on its plan to accelerate spending in 2018 as it looks to boost revenue growth, Keirstead tells investors in a research note. He believes the commentary suggests margins will indeed move into the single digit range. He notes that on its Q2 earnings call, MicroStrategy warned operating margins would decline to 5%-10% "if necessary." Keirstead keeps a Hold rating on the shares.
09/21/17
SBSH
09/21/17
NO CHANGE
Target $133
SBSH
Neutral
MicroStrategy price target lowered to $133 from $191 at Citi
Citi analyst Walter Pritchard cut his price target for MicroStrategy shares to $133 saying a recurring revenue multiple is less relevant given the lack of valuation support in the shares. The analyst points out the MicroStrategy's CEO controls 68% of voting power and is widely viewed as not wanting to sell the company. This limits of the scope of potential shareholder activism and likely prevents a forced private takeout, Pritchard tells investors in a research note partially titled "Does recurring revenue even matter anymore? Taking valuation back to FCF based." He keeps a Neutral rating on the shares.
IBM IBM
$146.48

-0.3 (-0.20%)

09/12/17
MSCO
09/12/17
NO CHANGE
MSCO
Overweight
Morgan Stanley sees new evidence of scaling of IBM's Watson Health
After hosting a meeting with Deborah DiSanzo, General Manager of IBM Watson Health, Morgan Stanley analyst Katy Huberty noted that the unit grew patients that used cognitive technologies by ten times in one year to 40,000 from 4,000. Additionally, the number of hospitals using Watson for Oncology and Watson for Genomics more than doubled, to 89 from 27 last year, added Huberty. The analyst, who sees IBM as uniquely positioned to address the $2T of wasted spending on health care, keeps an Overweight rating on the stock.
08/07/17
BERN
08/07/17
NO CHANGE
BERN
IBM Infrastructure Services may not recover in 2H17, says Bernstein
After IBM predicted that the revenue growth of its Infrastructure Services, or IS, business would rebound in 2H17, Bernstein analyst A.M. (Toni) Sacconaghi, Jr says this target won't be "a slam dunk" for the company. He notes that the company's overall services backlog, which he says has historically been a good proxy for IS, is down 4% year-over-year. Additionally, he is worried " about potential financial incentives IBM may have provided to IS customers to extend/re-new existing contracts early." The analyst says the company remains "in a turnaround," and he keeps a Sector Perform rating.
09/05/17
UBSW
09/05/17
NO CHANGE
Target $152
UBSW
Neutral
Blockchain and cognitive computing IBM's best recovery chance, says UBS
UBS analyst Steven Milunovich noted IBM's (IBM) legacy business remains in decline but he thinks technologies such as blockchain and cognitive computing are its best hope for recovery. The analyst sees blockchain as a differentiated growth opportunity and he believes IBM is ahead of Microsoft (MSFT), which is also looking to monetize the technology. Milunovich said IBM's earnings momentum is mediocre and he remains concerned about the company's 2018 outlook. Milunovich maintained his Neutral rating and $152 price target on IBM shares.
INFY Infosys
$14.51

-0.04 (-0.27%)

09/18/17
09/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Caterpillar (CAT) upgraded to Buy from Neutral at UBS with analyst Steven Fisher saying his firm's latest analysis of private non-residential construction ex-Power shows a re-acceleration in activity in the fourth quarter and mid-single digit growth into 2018. 2. Mednax (MD) upgraded to Overweight from Sector Weight at KeyBanc analyst Jason Gurda saying he sees the company's operating headwinds moderating over the next few quarters and growth in its third specialty, radiology, accelerating in the the near-term. 3. Infosys (INFY) upgraded to Neutral from Sell at Goldman Sachs with the firm saying management uncertainty and guidance risk is already priced in. 4. Klondex Mines (KLDX) upgraded to Buy from Hold at Canaccord. 5. BP (BP) upgraded to Outperform from Market Perform at BMO Capital with analyst Brendan Warn saying he thinks the company's free cash flow will be boosted by "delivery of new upstream volumes, premium downstream product demand and improving (refining marker margin)." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/17/17
GSCO
09/17/17
UPGRADE
GSCO
Neutral
Infosys upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs upgraded Infosys to Neutral saying management uncertainty and guidance risk is already priced in.
08/28/17
08/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Infosys (INFY) upgraded to Buy from Outperform at CLSA. 2. Plains All American (PAA) was upgraded to Strong Buy from Outperform at Raymond James and to Outperform from Market Perform at BMO Capital. 3. Fiat Chrysler (FCAU) upgraded to Neutral from Underperform at BofA/Merrill with analyst John Murphy citing improved earnings and a "slightly" better balance sheet. 4. ENEL Generacion (EOCC) upgraded to Sector Perform from Underperform at Scotiabank. 5. Pebblebrook Hotel (PEB) upgraded to In Line from Underperform at Evercore ISI with analyst Steve Sakwa citing an improved ramp-up forecast. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/28/17
DBAB
08/28/17
UPGRADE
DBAB
Buy
Infosys upgraded to Buy from Hold at Deutsche Bank
ADP ADP
$111.40

0.69 (0.62%)

08/16/17
JPMS
08/16/17
NO CHANGE
Target $99
JPMS
Neutral
ADP 'reasonably priced' ahead of Pershing webcast, says JPMorgan
JPMorgan analyst Tien-tsin Huang views ADP as "reasonably priced" ahead of Pershing Sqaure's activist webcast tomorrow morning. Pershing's involvement, however, could be a "net win" for the company longer-term, Huang tells investors in a research note. The analyst keeps a Neutral rating on ADP with a $99 price target.
08/17/17
SBSH
08/17/17
NO CHANGE
Target $110
SBSH
Neutral
ADP placed on positive Catalyst Watch list at Citi
Citi analyst Ashwin Shirvaikar placed on ADP on its 90-day positive Catalyst Watch list while raising his price target for the shares to $110 from $98. The analyst keeps a Neutral rating on the name. Regardless of the outcome with Pershing Square, ADP will "tighten up its planning, delivery and operations in order to show it offers a better/safer alternative," Shirvaikar tells investors in a research note. He believes this should lead to a higher "base case" outcome for ADP, or $110 per share.
08/17/17
EVER
08/17/17
NO CHANGE
Target $115
EVER
In Line
ADP will have difficulty reaching Pershing's margin goal, says Evercore ISI
Evercore ISI analyst David Togut believes Pershing Square today made a "strong case" for EBIT margin expansion at ADP. The analyst, however, believes 1,200 basis points of EBIT margin expansion by fiscal year 2022 will be "very difficult to achieve." Togut keeps an In Line rating on ADP with a $115 price target.
08/14/17
STFL
08/14/17
NO CHANGE
Target $108
STFL
Hold
Stifel analysis suggests ADP's margins are 'reasonable'
Stifel analyst David Grossman says that while he looks forward to Pershing Square's presentation Thursday, his analysis suggests ADP's margins are "reasonable" based on its business model and current mix of business. Management and the board has worked hard to balance growth and profitability against stability, Grossman tell investors in a research note partially titled, "They May Have a Case, Though Not Immediately Obvious to Us." The analyst believes any effort to improve margins will need to be viewed in the context of that trade-off. He also questions how much near-term opportunity has already been priced in the shares post Pershing's involvement. Grossman has a Hold rating on ADP with a $108 price target.
ORCL Oracle
$48.90

0.21 (0.43%)

10/04/17
STFL
10/04/17
NO CHANGE
Target $53
STFL
Buy
Oracle going after Splunk with HACS offering, says Stifel
After Oracle (ORCL) announced Highly Automated Cyber Security, or HACS, a new offering to address cybersecurity threats, Stifel analyst Brad Reback noted that Larry Ellison "went quite hard" after Splunk (SPLK), specifically addressing advantages of its product compared to Splunk and referring to HACS as the "nerve center," which is term Splunk often uses when referring to its own solutions. Reback, who would not be surprised to see Splunk under pressure after Oracle's OpenWorld presentation, keeps a Buy rating and $53 price target on Oracle shares.
10/04/17
10/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Buy at Nomura Instinet. 2. Oracle (ORCL) initiated with an Overweight at Piper Jaffray. 3. Domino's Pizza (DPZ) initiated with a Neutral at Credit Suisse. 4. AutoNation (AN) initiated with a Buy at Berenberg. 5. FuelCell (FCEL) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/17
BOFA
10/02/17
NO CHANGE
BOFA
Oracle shares can reach $80, says BofA/Merrill
BofA/Merrill analyst Kash Rangan estimates that Oracle's (ORCL) EPS can reach $4-$5 in fiscal 2022, as Rangan believes that the company can meet its goal of generating $20B in revenue from its cloud businesses. Moreover, Rangan believes that the company's P/E multiple can reach 21 times, in-line with Microsoft's (MSFT) multiple, enabling Oracle's stock to reach $80 per share . The analyst keeps a $62 price target and a Buy rating on Oracle.
10/04/17
PIPR
10/04/17
INITIATION
Target $55
PIPR
Overweight
Oracle initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Alex Zukin started Oracle with an Overweight rating and $55 price target. The company is an "Enterprise Juggernaut that has doubled down on a cloud transition," Zukin tells investors in a research note partially titled "A Lannister Always Pays His Debts." He believes Oracle has the "technical and sales resources" to successfully navigate this transition and return to consistent top and bottom line growth.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:47
07/21/18
07/21
12:47
07/21/18
12:47
Periodicals
Fiat Chrysler's Sergio Marchionne to step down, NYTimes reports »

Fiat Chrysler's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:43
07/21/18
07/21
12:43
07/21/18
12:43
Periodicals
Fiat Chrysler to name Jeep's Manley as CEO, Reuters reports »

Fiat Chrysler has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$187.21

-0.14 (-0.07%)

, TCEHY

Tencent

$0.00

(0.00%)

12:40
07/21/18
07/21
12:40
07/21/18
12:40
Periodicals
Alibaba, Tencent in talks to buy stake in WPP's Chinese unit, Reuters says »

Alibaba (BABA) and…

BABA

Alibaba

$187.21

-0.14 (-0.07%)

TCEHY

Tencent

$0.00

(0.00%)

WPP

WPP

$76.08

1.52 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, NFLX

Netflix

$361.33

-2.81 (-0.77%)

11:24
07/21/18
07/21
11:24
07/21/18
11:24
Periodicals
Amazon, Netflix to face tighter capital markets, Barron's says »

Since the Great…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 16

    Aug

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

, BLK

BlackRock

$503.01

-1.42 (-0.28%)

11:17
07/21/18
07/21
11:17
07/21/18
11:17
Periodicals
BlackRock, T. Rowe Price look like bargains, Barron's says »

With shares of many…

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

ALV

Autoliv

$104.08

-0.57 (-0.54%)

, VNE

Veoneer

$50.81

-1.81 (-3.44%)

11:12
07/21/18
07/21
11:12
07/21/18
11:12
Periodicals
Automotive spinoffs offer exposure to autonomous, electric future, Barron's says »

Last month, Autoliv (ALV)…

ALV

Autoliv

$104.08

-0.57 (-0.54%)

VNE

Veoneer

$50.81

-1.81 (-3.44%)

DLPH

Delphi Technologies

$44.78

-0.355 (-0.79%)

APTV

Aptiv

$92.95

-2.02 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

07:58
07/21/18
07/21
07:58
07/21/18
07:58
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

F

Ford

$10.56

-0.115 (-1.08%)

GM

General Motors

$39.39

0.08 (0.20%)

HMC

Honda

$29.18

-0.19 (-0.65%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$131.87

0.11 (0.08%)

VLKAY

Volkswagen

$0.00

(0.00%)

GOOG

Alphabet

$1,184.77

-2.37 (-0.20%)

GOOGL

Alphabet Class A

$1,198.05

-1.21 (-0.10%)

PFE

Pfizer

$37.33

-0.03 (-0.08%)

NVS

Novartis

$82.28

1.47 (1.82%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.38

0.44 (1.05%)

BA

Boeing

$354.92

-0.57 (-0.16%)

MRK

Merck

$62.51

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 08

    Aug

  • 15

    Aug

  • 22

    Aug

  • 10

    Sep

  • 10

    Sep

  • 18

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Oct

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/21/18
07/21
04:55
07/21/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FNWB

First Northwest Bancorp

$16.11

0.36 (2.29%)

17:48
07/20/18
07/20
17:48
07/20/18
17:48
Hot Stocks
First Northwest Bancorp names Terry Anderson chief credit officer »

First Northwest Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.75

-0.05 (-0.32%)

17:42
07/20/18
07/20
17:42
07/20/18
17:42
Hot Stocks
Freeport McMoRan CAO Michael Arnold to retire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

, XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

17:39
07/20/18
07/20
17:39
07/20/18
17:39
General news
Week ending ETF Scorecard: Financials lead, Energy slumps »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

IYR

DJ US Real Estate Index Fund

$80.23

-0.68 (-0.84%)

XLP

Consumer Staples Sector SPDR

$52.84

0.3 (0.57%)

XLY

Consumer Discretionary Sector SPDR

$112.15

-0.47 (-0.42%)

XLB

S&P Select Materials SPDR

$58.31

-0.21 (-0.36%)

XLF

Financial Select Sector

$27.57

0.065 (0.24%)

XLV

Health Care Select Sector SPDR

$86.74

-0.17 (-0.20%)

XLK

Technology Select Sector SPDR

$72.55

0.01 (0.01%)

XLI

Industrial Select Sector SPDR

$74.44

-0.09 (-0.12%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

SLV

iShares Silver Trust

$14.59

0.18 (1.25%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

UNG

United States Natural Gas Fund

$22.38

-0.06 (-0.27%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.62

0.03 (0.04%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.27

-0.335 (-0.29%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.78

-1.46 (-1.19%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.21

-0.35 (-0.34%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.005 (-0.01%)

IWD

iShares Russell 1000 Value

$123.07

-0.2897 (-0.23%)

IWF

iShares Russell 1000 Growth

$149.41

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$25.10

-0.095 (-0.38%)

, FUJIY

Fujifilm

$0.00

(0.00%)

17:25
07/20/18
07/20
17:25
07/20/18
17:25
Hot Stocks
Xerox, Centerview settle matters related to proposed Fuji tie-up »

On July 20, 2018, Xerox…

XRX

Xerox

$25.10

-0.095 (-0.38%)

FUJIY

Fujifilm

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

STON

StoneMor Partners

$3.61

-0.015 (-0.41%)

17:15
07/20/18
07/20
17:15
07/20/18
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneMor Partners »

Oaktree Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

$8.70

0.07 (0.81%)

17:11
07/20/18
07/20
17:11
07/20/18
17:11
Downgrade
Telefonica rating change at Goldman Sachs »

Telefonica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

, USO

United States Oil Fund

$14.15

0.025 (0.18%)

17:04
07/20/18
07/20
17:04
07/20/18
17:04
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 5.5K…

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

FXE

Euro Currency Trust

$112.46

0.83 (0.74%)

FXC

CurrencyShares Canadian Dollar Trust

$75.17

0.81 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.15

(0.00%)

17:02
07/20/18
07/20
17:02
07/20/18
17:02
Syndicate
Breaking Syndicate news story on Citizens Community Bancorp »

Citizens Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKD

Parker Drilling

$0.30

-0.0044 (-1.46%)

17:01
07/20/18
07/20
17:01
07/20/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Parker Drilling »

Whitebox Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

RSLS

ReShape Lifesciences

$1.47

-0.02 (-1.34%)

17:00
07/20/18
07/20
17:00
07/20/18
17:00
Hot Stocks
Breaking Hot Stocks news story on ReShape Lifesciences  »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOX

Box

$26.13

-0.26 (-0.99%)

16:57
07/20/18
07/20
16:57
07/20/18
16:57
Initiation
Box initiated at First Analysis »

Box initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDX

Aldeyra

$7.95

-0.15 (-1.85%)

16:53
07/20/18
07/20
16:53
07/20/18
16:53
Syndicate
Breaking Syndicate news story on Aldeyra »

Aldeyra files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLRE

Greenlight Capital Re

$14.00

-0.15 (-1.06%)

16:46
07/20/18
07/20
16:46
07/20/18
16:46
Hot Stocks
Greenlight Capital Re announces departure of COO »

Greenlight Capital Ry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVI

Retail Value

$34.56

0.2 (0.58%)

16:38
07/20/18
07/20
16:38
07/20/18
16:38
Hot Stocks
Breaking Hot Stocks news story on Retail Value »

Luxor Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.